Effectiveness of omalizumab in adolescent and adult patients with chronic idiopathic/spontaneous urticaria: a systematic review of 'real-world'evidence

JA Bernstein, A Kavati, MD Tharp, B Ortiz… - Expert opinion on …, 2018 - Taylor & Francis
Introduction: Chronic idiopathic/spontaneous urticaria (CIU/CSU) is a dermatological
condition characterized by itchy wheals and/or angioedema of continuous or intermittent …

Emerging biomarkers and therapeutic pipelines for chronic spontaneous urticaria

G Deza, PA Ricketti, AM Giménez-Arnau… - The Journal of Allergy …, 2018 - Elsevier
Chronic spontaneous urticaria (CSU) is defined as the appearance of evanescent wheals,
angioedema, or both, for at least 6 weeks. CSU is associated with intense pruritus and poor …

The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change

R Ertas, K Ozyurt, M Atasoy, T Hawro, M Maurer - Allergy, 2018 - Wiley Online Library
Background Omalizumab is an effective and well‐tolerated treatment for chronic
spontaneous urticaria (CSU). Markers and predictors of response are largely unknown, but …

[PDF][PDF] Total IgE levels are linked to the response of chronic spontaneous urticaria patients to omalizumab

K Weller, T Ohanyan, T Hawro, A Ellrich, G Sussman… - 2018 - repositori.upf.edu
For Peer Review Page 1 For Peer Review Total IgE levels are linked to the response of chronic
spontaneous urticaria patients to omalizumab Journal: Allergy Manuscript ID ALL-2018-00264 …

[HTML][HTML] Serum IgE as an immunological marker to predict response to omalizumab treatment in symptomatic chronic urticaria

MD Straesser, E Oliver, T Palacios, T Kyin… - The journal of allergy …, 2018 - ncbi.nlm.nih.gov
Chronic urticaria (CU) is defined as the appearance of pruritic migratory wheals,
angioedema, or both on most days of the week for more than 6 weeks. First line therapies for …

Cutting edge: biomarkers for chronic spontaneous urticaria

M Folci, E Heffler, GW Canonica… - Journal of …, 2018 - Wiley Online Library
Chronic spontaneous urticaria (CSU) is defined by the appearance of wheals and a variable
presence of angioedema which persists for at least 6 weeks. It represents the most common …

Effectiveness of omalizumab in chronic spontaneous urticaria assessed with patient‐reported outcomes: a prospective study

MN Ghazanfar, JG Holm… - Journal of the European …, 2018 - Wiley Online Library
Aim To examine the effectiveness of omalizumab (anti‐IgE) on symptoms and disease‐
related quality of life in chronic spontaneous urticaria (CSU) and to identify possible patient …

[HTML][HTML] Predicting chronic spontaneous urticaria symptom return after omalizumab treatment discontinuation: exploratory analysis

M Ferrer, A Giménez-Arnau, D Saldana… - The Journal of Allergy …, 2018 - Elsevier
Background Omalizumab is highly effective in controlling chronic spontaneous urticaria
(CSU) symptoms; however, patients can experience symptom return on treatment …

[PDF][PDF] Omalizumab in chronic urticaria: A comprehensive review.

EK Göncü, K Kızıltaç, T Leslie - Turkish Archives of …, 2018 - jag.journalagent.com
Omalizumab is a humanized monoclonal anti-immunoglobulin E which is originally
developed for the treatment of allergic respiratory disorders, but has been approved for the …

[PDF][PDF] Primjena omalizumaba kod kronične spontane urtikarije/angioedema: preporuke, iskustva i spoznaje

T DUVANČIĆ - Acta Med Croatica, 2018 - core.ac.uk
496 je kod ove bolesti utvrđena velika učestalost pozitivnih antinuklearnih antitijela (ANA),
ali su ona značajna samo kod udruženosti urtika sa simptomima sustavnog eritematoznog …